Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Hematologic

This prospective, multicenter, randomized, open-label, Phase 2, parallel, dose ranging, multidose trial will enroll patients into 3 Thrombosomes dose groups and 1 control liquid stored platelets (LSP) group in order to evaluate, in a dose-escalation manner, the safety, and impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in comparison to standard of care, LSP.
Hematologic
II
Sharma, Deva
NCT04631211
VICCHEM2118

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: